APRE 1.55 ▲ 3.33% Live Trading Data - Stocknear

Aprea Therapeutics Inc.

NASDAQ: APRE · Real-Time Price · USD
1.55
0.05 (3.33%)
At close: Sep 05, 2025, 3:59 PM
1.48
-4.52%
After-hours: Sep 05, 2025, 05:48 PM EDT
3.33%
Bid 1.48
Market Cap 9.03M
Revenue (ttm) 678.55K
Net Income (ttm) -13.85M
EPS (ttm) -2.25
PE Ratio (ttm) -0.69
Forward PE -1.12
Analyst Buy
Ask 1.58
Volume 19,806
Avg. Volume (20D) 51,166
Open 1.55
Previous Close 1.50
Day's Range 1.53 - 1.61
52-Week Range 1.41 - 5.01
Beta 1.58

About APRE

undefined

Industry n/a
Sector n/a
IPO Date n/a
Employees NaN
Stock Exchange n/a
Ticker Symbol APRE
Website n/a
Full Company Profile

Analyst Forecast

According to 0 analyst ratings, the average rating for APRE stock is "n/a." The 12-month stock price forecast is $n/a, which is a decrease of 0% from the latest price.

Stock Forecasts
3 months ago
+17.65%
Aprea Therapeutics shares are trading higher on co... Unlock content with Pro Subscription
5 months ago
+9.87%
Aprea Therapeutics shares are trading higher after the company announced it entered a medical transfer agreement with MD Anderson Cancer Center to explore APR-105 as a potential treatment for head and neck squamous cell carcinoma.